Connective Tissue Graft Workflow Template

Connective tissue graft.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Recipient site: Recipient site
Teeth: #Tooth number(s)
Pre-op recession: Pre-op recession
Donor site: Donor site

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Graft/defect support: Reason grafting required; defect/recession dimensions; site/tooth
Image support: Radiograph/CBCT/intraoral photo of defect
Material details: Graft/biologic/membrane/suture material and amount
Prognosis/follow-up: Healing expectations and follow-up plan

Procedure:
Recipient site prepared.
Partial thickness flap elevated.
Connective tissue harvested from palate.
Graft placed at recipient site.
Graft secured.
Flap repositioned over graft.
Sutured with: Suture material/size
Donor site sutured.
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Soft diet.
No brushing treated areas.
Rx: Prescription or none

NV: Next visit

Documentation requirements

Soft-tissue grafting is a documentation-heavy procedure family. The chart is the only durable record that the recession defect was real, the donor source was harvested or sourced as documented, the recipient was prepared as described, and the regenerative goal is testable on follow-up. Per AAP regenerative-therapy and mucogingival guidance, the 2018 World Workshop classification framework, ADA CDT descriptor language,'s periodontics chapter, a defensible CTG note must contain:

• Recipient tooth number(s) and surface(s) — universal numbering for the tooth/teeth receiving the graft (e.g., #6 buccal, #11 buccal). Specify which surfaces are treated. For D4273, the first tooth, position, or edentulous tooth position in the graft anchors the code; each additional contiguous tooth, position, or edentulous tooth position in the same graft site rolls onto D4283. The descriptor is graft-site-scoped (contiguous), not arch-scoped.
• Recession classification — Cairo RT1 / RT2 / RT3 (preferred current language; RT1 = no interproximal attachment loss, RT2 = interproximal CAL ≤ buccal CAL, RT3 = interproximal CAL > buccal CAL) or Miller Class I / II / III / IV. Predictable root coverage is achievable in RT1 / Miller I-II; partial coverage in RT2 / Miller III; not predictable in RT3 / Miller IV.
• Pre-op recession depth and width — site-specific recession in mm at the gingival zenith (depth from CEJ to gingival margin) and width at the CEJ. Pre-op KT band height in mm apical to the gingival margin. Pre-op probing depth and BOP at the recession site and the interproximal sites.
• Pre-op intraoral photograph of recession defect(s) — single strongest piece of audit evidence on D4273 / D4275 review. Capture pre-op buccal photo with retractor, and ideally a measured photo with a UNC-15 or color-coded probe at the gingival margin for documentation of the pre-op defect dimensions.
• Pre-op radiograph(s) — PA(s) of the recipient tooth and adjacent teeth confirming interproximal bone level (the determinant of RT1 vs RT2 vs RT3). Vertical bitewings when applicable. CBCT (D0364-D0368) is not routine for CTG but is sometimes used for thin-biotype implant sites or when bone dehiscence is suspected; document indication when taken.
• Donor site — palate (autogenous CTG) with anatomic location (e.g., right palate, premolar-to-molar zone, 2-3 mm from the gingival margin to preserve the marginal vasculature) or allograft / xenograft (product, manufacturer, type, lot number, dimensions — required by FDA tissue-tracking regulations for human-derived materials and best-practice for xenograft). Greater palatine artery and nasopalatine nerve must be respected; document depth and dimensions of the donor harvest (typically 1.0-1.5 mm thick, 8-15 mm long, 4-6 mm wide) and confirm that the harvest stayed within the safe zone.
• Periodontal diagnosis and AAP staging/grading where applicable — many CTG patients have generalized Stage I-II periodontitis (or none); document the diagnosis or note "no active periodontal disease, mucogingival defect only" so the indication for soft-tissue grafting is clearly mucogingival rather than periodontal.
• Medical and dental history — reviewed today; flag bisphosphonates / anti-resorptives (MRONJ risk for any oral surgical procedure, especially intravenous nitrogen-containing bisphosphonates and denosumab — note that MRONJ risk is lower for soft-tissue-only procedures than for bone surgery but should still be documented), anticoagulants (palatal harvest carries bleeding risk from greater palatine artery), immunosuppression, uncontrolled diabetes (HbA1c), smoking (smokers have well-documented poorer root-coverage outcomes per AAP), and history of head/neck radiation.
• Vitals — pre-op BP and pulse; many state boards and most surgical practices require these on operative visits. Palatal harvest bleeding can be brisk; baseline vitals matter.
• Informed consent / PARQ — risks specific to CTG: post-op pain and swelling at both recipient and donor sites, palatal bleeding (greater palatine artery), donor-site discomfort and slow healing (typically 2-4 weeks for palatal re-epithelialization), incomplete root coverage, recurrence of recession over time, sensitivity, asymmetric esthetic result, possibility that additional grafting will be needed, alternatives (no treatment with monitoring, desensitizing agents only, restorative coverage of recession with composite, allograft alternative if autogenous declined, FGG if KT augmentation is the priority over root coverage), no-treatment risks (continued recession, attachment loss, sensitivity, root caries, esthetic concerns). Note signed vs verbal.
• Anesthesia — agent, concentration, vasoconstrictor, technique (local infiltration buccal at recipient + greater palatine and nasopalatine blocks for donor harvest), and carpule count.
• Recipient incision design and technique — coronally advanced flap (CAF), modified CAF (Zucchelli), tunnel (Allen / Zabalegui), modified coronal tunnel (MCAT), VISTA (Zadeh), pinhole (Chao), envelope (Raetzke), laterally positioned flap, or double-papilla flap. Document the technique, the extent of the flap, vertical releases (if any), and the apical extent of the dissection. Modern minimally invasive technique (tunnel / pinhole / VISTA) preserves papillae and is increasingly the norm for esthetic-zone CTG.
• Recipient bed preparation — partial-thickness vs full-thickness dissection, root surface debridement, root surface conditioning (24% EDTA gel for smear-layer removal, citric acid, or tetracycline) when used, biotype assessment.
• Donor harvest technique (autogenous) — single-incision technique (SIT, Hürzeler-Weng) vs double-incision / trapdoor vs de-epithelialized FGG (Zucchelli). Document incision design, depth (1.0-1.5 mm typical), dimensions of harvested graft (length x width x thickness), and donor-site closure (continuous mattress with 4-0 / 5-0 chromic gut or PTFE; collagen plug or hemostatic sponge in donor bed; palatal stent considered for large harvests).
• Allograft / xenograft preparation (non-autogenous) — product (AlloDerm RTM, AlloDerm Ready-to-Use, Puros Dermis, Mucograft Seal, Mucograft, Fibro-Gide, OracELL, BellaDerm), lot number, rehydration protocol (saline, blood, PRF — typically 10-40 minutes per IFU), dimensions trimmed.
• Graft placement — graft positioned at the recipient bed, oriented (connective-tissue side toward periosteum / dermal side facing root for ADM), trimmed to fit, and secured. Document graft dimensions and orientation.
• Coronal flap advancement and primary closure — flap coronally advanced over the graft to fully cover the CTG (the regenerative goal); tension-free closure verified; suture material, size, and pattern (e.g., "5-0 Vicryl sling sutures x 4 + 6-0 Prolene papilla tacking sutures x 2 + 4-0 chromic mattress at donor x 3"); knot count when relevant. Graft coverage is one of the strongest predictors of root coverage outcome per AAP literature; document explicitly.
• Donor site closure (autogenous) — closure technique (continuous sling, mattress, or single interrupted), suture material, and any hemostatic adjunct (collagen plug, gelfoam, hemostatic sponge, palatal stent). Hemostasis confirmed before patient is dismissed.
• Hemostasis — achieved at both sites; method if notable (pressure, electrosurgery distant from graft, hemostatic agent).
• Complications — explicit "None" or describe (excessive palatal bleeding, perforation of donor flap, inadequate graft dimensions requiring second harvest, inability to achieve full coronal coverage of graft).
• Patient tolerance / response — tolerated well, vitals stable, no adverse events.
• Post-op instructions — soft / cold diet first 24-48 h then soft diet 2 weeks, no chewing on either surgical site, no brushing the recipient site for the prescribed window (typically 2-4 weeks; chlorhexidine 0.12% rinse BID instead, with cotton-swab application around graft after 1 week), no smoking, no straws / no spitting first 24 h, no pulling on the lip / cheek to look at the graft, expected swelling and bruising, ice intermittent first 24 h, palatal stent care if used, return precautions (uncontrolled bleeding from palate, increasing pain after 72 h, fever, suture loss before scheduled removal, graft displacement or visible exposure).
• Prescriptions — analgesic regimen (ibuprofen 600 mg q6h prn ± acetaminophen 500 mg alternating per current AAP and ADA pain-control guidance favoring NSAID-first protocols over routine opioids); chlorhexidine 0.12% gluconate rinse BID x 2 weeks; antibiotic per practice protocol (commonly amoxicillin 500 mg TID x 5-7 days, or doxycycline 100 mg BID; evidence for routine antibiotic prophylaxis in healthy CTG patients is mixed but is common practice when allograft / xenograft is used).
• Re-evaluation plan — suture removal at 7-14 days (PTFE / Prolene later, chromic gut self-resorbs); soft-tissue check at 3-4 weeks; 3-6 month re-evaluation with re-measured recession depth, width, and KT band and intraoral photo to assess root coverage against pre-op baseline. The regenerative endpoint (percent root coverage, KT gain, defect resolution) is what justifies the procedure.
• Provider signature and assistant initials.

Two phrases that defuse the most common audit questions: an explicit recession class with pre-op recession depth and KT band ("Cairo RT1, recession 4 mm, KT 1.5 mm, buccal #6"), and the donor source with technique and lot ("Single-incision palatal CTG, 12 x 5 x 1.2 mm, right palate" or "AlloDerm RTM 1 x 4 cm, lot ##, rehydrated 15 min in sterile saline"). Both track ADA descriptor language and AAP mucogingival expectations directly.

Common denial reasons

D4273 / D4275 are heavily reviewed soft-tissue codes. The most frequent reasons they are denied, downgraded, or recouped:

• Missing or weak recession documentation — chart says "CTG placed" without a recession class, pre-op recession depth, or pre-op KT band measurement. The single most common denial reason on D4273 review.
• No pre-op intraoral photo of the recession defect — increasingly an expected element on review by major commercial carriers and AAP-style chart audits. Pre-op photo with retractor and a measured probe at the gingival margin is the strongest piece of audit evidence; silence reads as a missed step.
• No pre-op radiograph confirming interproximal bone — recession class (Cairo RT1 vs RT2 vs RT3, Miller I vs III) is determined by interproximal attachment level, which requires PA imaging at the recipient site. Carriers commonly request imaging on review.
• Donor-site notes missing on D4273 — chart describes recipient prep and graft placement but is silent on palatal harvest. Auditors will downgrade to D4275 (non-autogenous fee) when donor surgical-site documentation is absent.
• Allograft lot number not recorded on D4275 — FDA tissue-tracking regulations and most carriers' clinical policies require the product, manufacturer, and lot number for human-derived acellular dermal matrices (AlloDerm, Puros Dermis, BellaDerm). Missing lot number can be cited as a documentation deficiency on audit.
• Recession class does not support root coverage — RT3 / Miller III-IV with significant interproximal attachment loss; carrier reviewer concludes the case did not have a regenerative indication for root coverage specifically and processes at a lower fee or denies entirely. AAP literature explicitly notes that complete root coverage is not predictable in RT3 / Miller IV; document realistic goals (KT augmentation, biotype conversion, partial coverage) when treating these cases.
• Multiple D4273 billed for one contiguous graft — only one D4273 per contiguous graft site; additional contiguous teeth bill D4283. Auto-rejected by graft-site edit. The most common per-tooth-billing error in the soft-tissue family.
• D4273 + D4270 same DOS / same site — pedicle-only and CTG with separate donor are mutually exclusive at the same site. D4270 is typically denied as inclusive of D4273.
• D4273 / D4275 billed without an established mucogingival or periodontal indication — chart shows no recession measurement, no KT band, no BoP, no sensitivity. The procedure is reported on a tooth with no documented mucogingival defect.
• Cosmetic-exclusion denials — some plans deny soft-tissue grafting for "esthetic" indications. Document progression, sensitivity, root caries risk, BoP, and patient symptoms to support medical necessity.
• Re-graft at a previously failed site without narrative — most carriers will not pay a second D4273 / D4275 on the same tooth within 24-60 months without a narrative documenting the failure mode and the regenerative rationale.
• Smoker / uncontrolled diabetic without risk-factor narrative — some clinical-policy bulletins flag these patients as higher-risk for regenerative failure and require an explicit narrative addressing risk before paying.
• Default-template chart notes — identical recession depths, KT bands, graft dimensions, suture protocols, and post-op instructions across multiple patients flagged as templating. Medicaid MCO and several commercial carriers run template-fingerprint review.
• Failure to schedule or document 3-6 month re-evaluation — the regenerative goal is the indication for the procedure; not following through with re-measurement and intraoral photos weakens the chart's defense if the case is later audited.
• Antibiotic prophylaxis prescribed without justification — flagged in chart audits even though it doesn't affect D4273 reimbursement directly. Routine antibiotic prophylaxis for periodontal soft-tissue surgery is not universally supported by the literature; document the indication.

Related templates